No effect of C-reactive protein on early atherosclerosis in LDLR-/-/human C-reactive protein transgenic mice

Thrombosis and Haemostasis

Volumn 99, Issue 1, 2008, Pages 196-201

  Torzewski, Michael ^a   Reifenberg, Kurt ^a   Cheng, Fei ^a   Wiese, Elena ^a   Küpper, Ines ^a   Crain, Jeanine ^a   Lackner, Karl J ^a   Bhakdi, Sucharit ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; CRP; LDLR mice

Indexed keywords

C REACTIVE PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PENTRAXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CROSS BREEDING; HUMAN; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TRANSGENIC MOUSE;

ANIMALS; AORTA; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; CROSSES, GENETIC; DIETARY FATS; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; LIPIDS; LIPOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, LDL; TIME FACTORS;

EID: 38349107269     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-10-0595     Document Type: Article

References (27)

1. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007; 49: 2129-2138.
2. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 2006; 113: 2128-2134.
3. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006; 113: 2135-2150.
4. Paul A, Ko KW, Li L, et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109: 647-655.
5. Trion A, de Maat MP, Jukema JW, et al. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/ human C-reactive protein transgenic mice. Arterioscler Thromb Vase Biol 2005, 25: 1635-1640.
6. Reitenberg K, Lehr HA, Baskal D, et al. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol 2005; 25: 1641-1646.
7. Hirschfield GM, Gallimore JR, Kahan MC, et al. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2005; 102: 8309-8314.
8. Tennent GA, Hutchinson WL, Kahan MC, et al. Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE(-/-) mice. Atherosclerosis 2007; 21: 21.
9. Ciliberto G, Arcone R, Wagner EF, et al. Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. Embo J 1987; 6: 4017-4022.
10. Price CP, Trull AK, Berry D, et al. Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein. J Immunol Methods 1997; 99: 205-211.
11. Eda S, Kaufmann J, Roos W, et al. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137-144.
12. Paigen B, Morrow A, Holmes PA, et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987; 68: 231-240.
13. Lehr HA, Sagban TA, Ihling C, et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 2001; 104: 914-920.
14. Lehr HA, Mankoff DA, Corwin D, et al. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997; 45: 1559-1565.
15. Lehr HA, van der Loos CM, Teeling P, et al. Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 1999; 47: 119-126.
16. Ishibashi S, Brown MS, Goldstein JL, et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92: 883-893.
17. Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioseler Thromb Vasc Biol 1999; 19: 2348-2354.
18. Bhakdi S, Torzewski M, Paprotka K, et al. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 2004; 109: 1870-1876.
19. Zhang SH, Reddick RL, Piedrahita JA, et at. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-471.
20. Piedrahita JA, Zhang SH, Hagaman JR, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992; 89: 4471-4475.
21. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
22. Lin CS, Xia D, Yun JS et al. Expression of rabbit C-reactive protein in transgenic mice. Immunol Cell Biol 1995; 73: 521-531.
23. Torzewski J. C-reactive protein and atherogenesis: new insights from established animal models. Am J Pathol 2005; 167: 923-925.
24. Müller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57: 321-347.
25. Buono C, Come CE, Witztum JL, et al. Influence of C3 deficiency on atherosclerosis. Circulation 2002; 105: 3025-3031.
26. Bhatia VK, Yun S, Leung V, et al. Complement Clq reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 2007; 170: 416-426.
27. Kovacs A, Tornvall P, Nilsson R, et al. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci USA 2007; 104: 13768-13773.